Onemednet Corp

Onemednet Corp(ONMD)股票分析

$5.139

+1.194 (+23.24%)收盤時

Loading chart…
最高
5.250
開盤
4.470
成交量加權均價
4.94
成交量
70.88K
市值
—
最低
4.430
成交金額
350.13K
企業價值/稅息折舊攤銷前利潤(TTM)
0.00

OneMedNet Corporation is a global provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data (RWD), through its OneMedNet iRWD solution. The Company provides solutions within the clinical image archives of healthcare providers. It de-identifies, searches, and curates a data archive locally, bringing a wealth of internal and third-party research opportunities to providers. By leveraging this extensive federated provider network, together with technology and in-house clinical expertise, the Company meets the rigorous RWD life science requirements. OneMedNet iRWD offers advanced technology, clinical expert curation, and service. Medical imaging and associated clinical data are indexed at each network site using artificial intelligence (AI)/ machine learning (ML) technology. This includes EHR, radiology, cardiology, lab, path, and others. In addition to its customized data packages, it also offers regulatory-grade, pre-packaged imaging RWD sets.

AI 分析 of Onemednet Corp (ONMD)

買進

Onemednet Corp appears to be a good buy right now due to its recent significant revenue growth of 242% from Q2 2026 and a strong 21.78% increase in stock price over the last five days. However, the company still faces risks with a current ratio of only 0.28, indicating potential liquidity issues.

估值指標

Onemednet Corp(ONMD)目前預期本益比為 0.00,5 年平均預期本益比為 0.00。

預期本益比

嚴重低估
5 年均值 P/E
0.00
目前P/E
0.00
高估
0.00
低估
0.00

預期 EV/EBITDA

嚴重低估
5 年均值 EV/EBITDA
0.00
目前EV/EBITDA
0.00
高估
0.00
低估
0.00

預期股價營收比

嚴重低估
5 年均值 P/S
0.00
目前P/S
0.00
高估
0.00
低估
0.00

Alphio AI 對 ONMD 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%ONMD

$0.77

情境價格

基

基準

基準 · 50%ONMD

$0.68

情境價格

悲

悲觀

悲觀 · 25%ONMD

$0.57

情境價格

持有 ONMD 的大戶

E

Exencial Wealth Advisors, LLC

+ 持有ONMD

-2.95%

3個月報酬率

事件時間軸

2026-11-04 (ET)

09:30:00

OneMedNet Receives Mid Six-Figure Reorder to Support AI Radiology Model Development

2026-11-03 (ET)

09:00:00

OneMedNet Secures High Six-Figure Add-On Order, Data Volume Up 150%

2026-10-19 (ET)

09:30:00

OneMedNet Partners with Pharma Intelligence Provider

2026-10-07 (ET)

09:00:00

OneMedNet Partners with Mediplexus for Data Supply

2026-09-30 (ET)

09:00:00

OneMedNet Signs Seven-Figure Multi-Year Agreement

資訊

ONMD 常見問題 —— 由 Alphio AI 解答

OneMedNet Corporation is a global provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data (RWD), through its OneMedNet iRWD solution. The Company provides solutions within the clinical image archives of healthcare providers. It de-identifies, searches, and curates a data archive locally, bringing a wealth of internal and third-party research opportunities to providers. By leveraging this extensive federated provider network, together with technology and in-house clinical expertise, the Company meets the rigorous RWD life science requirements. OneMedNet iRWD offers advanced technology, clinical expert curation, and service. Medical imaging and associated clinical data are indexed at each network site using artificial intelligence (AI)/ machine learning (ML) technology. This includes EHR, radiology, cardiology, lab, path, and others. In addition to its customized data packages, it also offers regulatory-grade, pre-packaged imaging RWD sets. It operates in the Industrials sector (COMMERCIAL PHYSICAL AND BIOLOGICAL RESEARCH industry).

Onemednet Corp appears to be a good buy right now due to its recent significant revenue growth of 242% from Q2 2026 and a strong 21.78% increase in stock price over the last five days. However, the company still faces risks with a current ratio of only 0.28, indicating potential liquidity issues.

暫無貼文

註冊或登入後參與討論

相關文章

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易